[Cloning and expression of MHC class I chain-related gene A in E. coli]. 2010

Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
Institute of Blood Transfusion, Blood Center of Zhejiang Province, Key Laboratory for Blood Safety Research Subordinated to Ministry of Health, Hangzhou 310006, Zhejiang Province, China.

In order to construct prokaryotic expression system of MHC classI chain-related gene A (mica) and purify MICA protein, RNAs were extracted from the peripheral blood samples and mica cDNA fragments were obtained by RT-PCR method. The cDNA for mica was ligated with cloning vector by TOPO method. The recombinant cloning vector and prokaryotic expression vector pET-28a were digested by two restriction enzymes and ligated to construct pET-28a-MICA recombinant expression vector, then the pET-28a-MICA vector was transformed and expressed in E. coli BL21 DE3. The recombinant protein was purified by Ni-NTA Spin method. The results showed that the recombinant MICA protein expressed with soluble form in host with pET-28a-MICA vector after IPTG induction. The recombinant target protein was obtained by Ni-NTA spin purification. In conclusion, this study has constructed prokaryotic expression system of mica gene and has purified MICA protein which would help to explore the interaction between MICA and transplantation immunology.

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
March 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
January 2006, Cytotherapy,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
November 1995, Science (New York, N.Y.),
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
January 1994, Immunogenetics,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
January 2003, Methods in molecular biology (Clifton, N.J.),
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
January 2008, Neoplasma,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
March 2006, Human immunology,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
January 1987, Progress in clinical and biological research,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
December 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
Yan-Ming He, and Su-Dan Tao, and Yan-Ling Ying, and Fa-Ming Zhu, and Hang-Jun Lü, and Li-Xing Yan
May 2014, Tissue antigens,
Copied contents to your clipboard!